An interventional study of Internet-Based Intervention and Survey Administration in Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, sponsored by City of Hope Medical Center. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-19.
Sponsored by City of Hope Medical Center · Not applicable, Interventional, and Supportive care
This clinical trial determines how well the oncpatient mobile application work in assisting patients undergoing radiation treatment. Radiation therapy can be complex. The technology, daily treatments, and possible side effects can be confusing to prevent and manage. Traditional radiation patient education includes a large amount of information, including details of treatment logistics, side effect prevention, and management. However, this information is not always readily accessible or memorable through the long course of therapy, and critical details can be missed. Oncpatient is a mobile application intended to be a more convenient and accessible form of patient education and guidance that is readily available to help patients and their caretakers navigate through radiation treatment.
PRIMARY OBJECTIVE:
I. To determine the feasibility of implementing a mobile application designed to be an educational resource designed for patients undergoing radiation treatment.
SECONDARY OBJECTIVES:
I. To assess patient opinions on the usability and helpfulness of the mobile application in helping them through radiation treatments.
II. To assess satisfaction with the mobile application and radiation treatment. III. To assess opinions on existing or new features for the mobile application to be given to future patients.
OUTLINE:
Patients use the oncpatient mobile application over the course of radiation therapy. Patients also complete a survey on the final day of radiation treatment.
1,464 studies on the registry are indexed under Hematologic Neoplasms; 433 are open to participants now.
This study's enrollment of 20 is below the median of 45 across 1,068 interventional studies indexed under Hematologic Neoplasms.
Browse Hematologic Neoplasms studies →City of Hope Medical Center is the lead sponsor of 670 studies on the registry; 181 are open to participants now.
Of its 30 completed or terminated interventional studies of FDA-regulated products, 12 (40%) have results posted.
Counted across the registry records on this site, refreshed daily.
Has regular access to a mobile device.
Exclusion Criteria:
Patients use the oncpatient mobile application over the course of radiation therapy. Patients also complete a survey on the final day of radiation treatment.
Other: Internet-Based Intervention · Other: Survey Administration
Use oncpatient mobile application
Complete survey
Completion rate
The percent of patients who indicate in the survey that they were able to download the application and use it at least once during radiation will be defined as the completion rate.
Time frame: Up to 1 year
Patient opinions on the usability and helpfulness of the mobile application in helping them through radiation treatments
Survey responses and collected demographic data will be evaluated with descriptive statistics where possible. Free-text responses will be recorded and utilized by the application developers to inform future iterations of the application.
Time frame: Up to 1 year
Satisfaction with the mobile application and radiation treatment
Survey responses and collected demographic data will be evaluated with descriptive statistics where possible. Free-text responses will be recorded and utilized by the application developers to inform future iterations of the application.
Time frame: Up to 1 year
Opinions on existing or new features for the mobile application to be given to future patients
Survey responses and collected demographic data will be evaluated with descriptive statistics where possible. Free-text responses will be recorded and utilized by the application developers to inform future iterations of the application.
Time frame: Up to 1 year
This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
City of Hope Medical Center